Altria vs. BAT: Similar Yields, Very Different Dividend Risk

Altria and British American Tobacco can look interchangeable on an income screen. In the source snapshot, both yielded a little more than 6%, and each had paid roughly 78% of trailing free cash flow as dividends through June 2026. The similarity ends once investors examine how each company generated the cash and how much balance-sheet risk sits behind the payout.

Altria entered the comparison with the steadier record. TIKR's underlying data showed its annual dividend consuming between 74.6% and 82.0% of free cash flow in every year from 2021 through 2025. The same analysis put net debt at about 1.4 times EBITDA and interest coverage above 13 times. Those figures do not remove the long-term decline in U.S. cigarettes, but they give management more room to absorb volatility than a highly leveraged issuer would have.

Fresh third-quarter information strengthens that case. Altria said on October 29 that adjusted diluted earnings per share rose 4.8% to $1.52, while revenue net of excise taxes increased 3.6% to $5.44 billion. It raised full-year adjusted EPS guidance to $5.66 to $5.74, compared with $5.42 in 2025. The company also increased its annualized dividend to $4.44 per share, its 61st dividend increase in 57 years, and retained a goal of mid-single-digit dividend growth through 2028.

That cash return is large rather than effortless. Altria paid $5.3 billion of dividends during the first nine months of 2026 and repurchased $735 million of stock. Its cigarette franchise still faces volume decline, pressure on consumers' discretionary income and migration toward vapor products. Nicotine pouches offer a route to offset some of that erosion, but they have not eliminated dependence on smokeable products.

British American Tobacco offers a different tradeoff. BAT reported that first-half revenue rose 1.4% to £12.24 billion, or 2.9% at constant exchange rates. New Categories revenue grew 18% at constant rates, led by modern oral products, and their contribution margin improved by 3.3 percentage points to 13.3%. That progress matters because a more profitable smoke-free portfolio is central to replacing combustible volume over time.

The cash picture is less smooth. TIKR's data showed BAT's free cash flow falling from £9.64 billion in 2024 to £5.79 billion in 2025, pushing the dividend to 91.4% of free cash flow that year. It calculated trailing free cash flow of £6.85 billion through June 2026, bringing the trailing payout back to about 78%. BAT separately reported £2.29 billion of free cash before dividends in the first half of 2026 and kept its full-year goal for operating cash conversion above 95%. It also reported adjusted net debt of £31.97 billion and expects leverage to fall within 2.0 to 2.5 times adjusted EBITDA by year-end.

BAT was cheaper in the source snapshot, at 10.9 times forward earnings versus 11.9 times for Altria, and its 6.3% indicated yield was close to Altria's 6.5%. U.S. investors must also account for sterling translation, because the dollar value of BAT's dividend changes with exchange rates.

The decision is therefore not simply which stock pays the larger percentage today. Altria offers the more consistent cash-coverage history and lighter leverage, while BAT offers a lower valuation and faster growth in smoke-free categories. BAT could close the quality gap if its cash-conversion target and deleveraging plan hold, but investors should demand that evidence before treating the two payouts as equally durable.